There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC A61K38/12
Pages in category "CPC A61K38/12"
The following 33 pages are in this category, out of 33 total.
2
- 20250152660. Sco-spondin-derived Polypeptide (AXOLTIS PHARMA)
- 20250170204. Oral Octreotide Administered (Amryt Endo, .)
- 20250170205. Composition Bl-8040 (BioLineRx .)
- 20250170206. Composition Bl-8040 (BioLineRx .)
- 20250170207. Composition Bl-8040 (BioLineRx .)
- 20250170208. Composition Bl-8040 (BioLineRx .)
- 20250170209. Dosing Regimens (Apellis Pharmaceuticals, .)
- 20250170210. Dosing Regimens (Apellis Pharmaceuticals, .)
- 20250186539. Methods Treating Cancer (BicycleTx Limited)
- 20250186540. Vipr2 Antagonist Pe (ICHIMARU PHARCOS ., .)
- 20250186541. Dll3 Targeting Peptides (MARIANA ONCOLOGY .)
- 20250195606. Method Treatin (RHYTHM PHARMACEUTICALS, .)
- 20250195607. Composition Bl-8040 (BioLineRx .)
- 20250228916. Method (ROYAL COLLEGE OF SURGEONS IN IRELAND)
H
N
T
- The Johns Hopkins University Patent Application Trends in 2024
- The Regents of the University of California Patent Application Trends in 2025
- The Regents of The University Of California Patent Application Trends in 2025
- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Patent Application Trends in 2024
- The Trustees of Columbia University in the City of New York Patent Application Trends in 2024